ASND Earnings

Quarterly EPS
$0.00
Q3 2017
$-0.05
Q4 2017
$-0.04
Q1 2018
$-0.08
Q2 2018
$0.01
Q3 2018
$-0.06
Q4 2018
$-0.04
Q1 2019
$-0.07
Q2 2019
Latest Revenue157.0K
Latest Net Income-41087000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2019-$0.07157.0K-41087000-98.3%+12.5%
Q1 2019-$0.04-27412000+0.0%
Q4 2018-$0.061.5M-36173000-65.4%-20.0%
Q3 2018$0.0140.8M5.2M+50.1%
Q2 2018-$0.089.0M-43845000+156.7%-100.0%
Q1 2018-$0.048.2M-21078000+186.9%+20.0%
Q4 2017-$0.054.3M-27263000-50.0%-25.0%
Q3 201727.2M-878000+1,025.2%
Q2 2017-$0.043.5M-20215000
Q1 2017-$0.052.9M-21782000
Q4 2016-$0.048.5M-15414000
Q3 2016-$0.042.4M-18494000
Ascendis Pharma A/S Ordinary Share (ASND) — Earnings